Contents: Preface Part I Introduction: Critical cases in global health innovation, Andrew F. Cooper, John J. Kirton and Michael A. Stevenson. Part II Responding to Pandemics: Severe Acute Respiratory Syndrome: Epidemic of fear SARS and the political economy of contagion, Andrew T. Price-Smith and Yanzhong Huang Lessons from SARS: past practice, future innovation, Carolyn Bennett The WHO and SARS: the challenge of innovative responses to global health security, Adam Kamradt-Scott. Part III Accessing Affordable Medicines: SARS and avian influenza in China and Canada: the politics of controlling infectious disease, Sonny Shui-Hing Lo The role of civil society in pandemic preparedness, Kathryn White and Maria Banda In-flew-enza: pandemic inluenza and its security implications, Yanzhong Huang. Part IV Accessing Affordable Medicines: Coming to terms with Southern Africa's HIV/AIDS epidemic, Hany Besada The renovation of institutions to support drug access: is it enough?, Jillian Clare Cohen-Kohler Global health governance from below: access to AIDS medicines, international human rights law, and social movements, Lisa Forman. Part V Conductiong Campaigns Against Chronic Illness Polio and Tobacco: Rotary International and eradicating polio, Robert Scott, Wilfred Wilkinson and John Eberhard Globalisation and the politics of health governance: the framework convention on tobacco control, Jeff Collin and Kelley Lee. Part VI Defining Future Directions in Global Health Governance: Forging the trade link in global health governance, Benedikte Dal, Laura Sunderland and Nick Drager Explaining compliance with G8 health commitments, 1996a 2006, John J. Kirton, Nikolai Roudev, Laura Sunderland and Catherine Kunz Global health initiatives: a healthy governance response?, Caroline Khoubesserian. Part VII Conclusion: Innovation in global health governance, John J. Kirton and Andrew F. Cooper Bibliography Index.
No takes yet. Share an insight, caveat, or question.
Andrew F. Cooper (2009) studied this question.